Tivozanib for Recurrent Glioblastoma
Clinical trial NCT01846871 · COMPLETED
Trial details
- NCT number
- NCT01846871
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2014-09-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.